Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gland Pharma
Pharma
Granules receives Form 483 over poor document controls and more
From truckloads of torn documents to avian incursions, Granules' new manufacturing reprimand from the FDA is alarming no matter which way you read it.
Fraiser Kansteiner
Sep 19, 2024 10:11am
After rumors, Gland 'not aware' that it's up for sale
Nov 29, 2022 9:45am
J&J's Momenta calls infringement against Mylan and its partners
May 25, 2022 8:59am
Tough decisions for Indian pharmas who do business with Russia
Mar 9, 2022 9:38am
Dr. Reddy's, Insilico-Taisho, Fosun's Gland—FiercePharmaAsia
Oct 23, 2020 10:10am
FiercePharmaAsia—Big Pharma, Fosun, Arcus-Taiho
Sep 22, 2017 9:50am
